Chest
Contemporary Reviews in Sleep MedicineInsomnia and Risk of Cardiovascular Disease
Section snippets
Defining and Measuring Insomnia
Several diagnostic systems have used varying definitions of insomnia, which may have contributed to inconsistencies in clinical practice and research. The current classification of insomnia in the newest editions of both the International Classification of Sleep Disorders, 3rd edition, and the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, have attempted to clarify past nosologies by simplifying the insomnia criteria. The previous classification systems had differentiated
Insomnia and CVD Pathophysiology: Underlying Mechanisms
Although the pathogenesis of insomnia and CVD is not fully understood, there are multiple mechanisms underlying this relationship, including dysregulation of the hypothalamic-pituitary axis (HPA) axis,24, 35, 36, 37, 38 abnormal modulation of the autonomic nervous system, and increased sympathetic nervous system (SNS) activity,39 increased systemic inflammation,40, 41 and increased atherogenesis19, 42 (Fig 1). Chronic insomnia is considered a state of conditioned hyperarousal43 and thought to
Hypertension
Existing research mostly supports an association between insomnia and incident HTN.6, 7, 8, 9, 61 One of the largest prospective epidemiologic studies, from the Penn State cohort, followed 786 individuals with chronic insomnia who were free of baseline HTN for 7½ years. Participants were recruited from a random general community sample and underwent PSG at baseline. Chronic insomnia was defined as a complaint of insomnia for ≥ 1 year. After adjustment for numerous potential confounders, chronic
Coronary Heart Disease
A number of prospective observational studies have demonstrated that insomnia is associated with increased risk of CHD, recurrent ACS, and mortality.10, 11, 12, 13, 14, 15, 16 Further, there is a high prevalence of insomnia among patients with comorbid CHD: an astounding one third of patients presenting with initial ACS during and after hospitalization report insomnia.15
One of the first large prospective population studies associating insomnia with incident CHD was the Nord-Trondelag Health
Heart Failure
There is a high prevalence of insomniac symptoms among patients with HF, ranging from 23% to 73%. There are many reasons insomnia may be a result of HF, such as disease-related anxiety and depression, medications, and Cheyne-Stokes respiration. There are also longitudinal data from some,17, 65 although not all, studies66 that have reported insomnia to precede the onset of HF. In a middle-aged prospective cohort of 2,322 men, self-reported symptoms of insomnia predicted increased risk of
Insomnia and Overall CVD Risk and Mortality
Several studies have also reported that insomnia is associated with both CVD risk and CVD mortality. A systematic review and meta-analysis of prospective cohort studies showed that 122,501 subjects free of baseline CVD disease with insomnia (assessed using a questionnaire) had a 45% increased risk (95% CI, 1.29-1.62) of the development of or death from CVD during a 3- to 20-year follow-up.67 Another meta-analysis of 17 cohort studies with 311,260 subjects free of baseline CVD demonstrated a
Unanswered Questions
Variations in the measurement and definition of insomnia continue to be a research challenge despite attempts at expert consensus regarding the best means of identifying and defining insomnia for research purposes. There is a need to further clarify the roles of short sleep duration vs poor sleep quality on CVD and to better define subgroups at increased risk. Future research may benefit from attempting to dissect the distinct as well as overlapping influences of insomnia and short sleep
Acknowledgments
Financial/nonfinancial disclosures: None declared.
References (68)
- et al.
Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012
Sleep Med
(2015) - et al.
Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey
Biol Psychiatry
(2011) - et al.
Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm Female Coronary Risk Study
J Psychosom Res
(2003) - et al.
Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies
Int J Cardiol
(2014) International classification of sleep disorders-third edition: highlights and modifications
Chest
(2014)- et al.
Quantitative criteria for insomnia
Behav Res Ther
(2003) - et al.
Chronic insomnia and activity of the stress system: a preliminary study
J Psychosom Res
(1998) - et al.
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
J Am Coll Cardiol
(2004) Hyperarousal and insomnia: state of the science
Sleep Med Rev
(2010)- et al.
Sleep loss and inflammation
Best Pract Res Clin Endocrinol Metab
(2010)
Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight
J Allergy Clin Immunol
Depression as a predictor for coronary heart disease. a review and meta-analysis
Am J Prev Med
Self-reported sleep duration and coronary heart disease mortality: a large cohort study of 400,000 Taiwanese adults
Int J Cardiol
Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data
Arch Intern Med
Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group
Sleep
Clinical guideline for the evaluation and management of chronic insomnia in adults
J Clin Sleep Med
Insomnia with objective short sleep duration and incident hypertension: the Penn State cohort
Hypertension
Insomnia with objective short sleep duration is associated with a high risk for hypertension
Sleep
Persistent insomnia is a predictor of hypertension in Japanese male workers
J Occup Health
Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence
Am J Hypertens
Insomnia and the risk of acute myocardial infarction: a population study
Circulation
The association between insomnia symptoms and mortality: a prospective study of U.S. men
Circulation
Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population
J Intern Med
Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study
Sleep
Clinical correlates of insomnia in patients with acute coronary syndrome
Int Heart J
Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies
Eur Heart J
Insomnia and the risk of incident heart failure: a population study
Eur Heart J
Sleep-disordered breathing and incident heart failure in older men
Am J Respir Crit Care Med
Short sleep duration and incident coronary artery calcification
JAMA
Do insomnia complaints cause hypertension or cardiovascular disease?
J Clin Sleep Med
Objective but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia
Sleep
The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response
Sleep
Sleep: important considerations for the prevention of cardiovascular disease
Curr Opin Cardiol
Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American Heart Association
Circulation
Cited by (0)
FUNDING/SUPPORT: This work was supported by National Institutes of Health Grant [NIH 5T32HL007901].